ArticleMedizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V2026
Polygenic scores in psychiatric research and clinical practice.
Article in Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polygenic scores are nowadays common tools in psychiatric genetic research and are also increasingly applied in clinical settings. In this article, we give an overview of polygenic scores in psychiatric research, focusing on recent trends and novel applications such as using polygenic scores in family studies. Furthermore, we discuss use cases of polygenic scores in clinical studies and clinical practice, for instance using polygenic scores to predict treatment response to medication. While some challenges of polygenic scores are not unique to psychiatry (e.g. limited reliability or transferability across ancestries), we also highlight the specialties of using polygenic scores in psychiatric research and clinical practice (e.g. clinical and biological heterogeneity across and within psychiatric conditions), as well as limitations of other applications beyond research, e.g. using polygenic scores for psychiatric conditions for embryo selection. We further make the case for careful communication of genetics to patients and the general public. We conclude by providing an outlook which includes future directions and applications of polygenic scores in psychiatric research and clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.